Note: Ingredients listed on restricted chemical lists
EC/CAS
618-498-9/9016-87-9
Name of the chemical
4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)
Concentration
25 - 50
EC/CAS
247-426-5/26040-51-7
Name of the chemical
Bis(2-ethylhexyl) tetrabromophthalate; Tetrabromophthalic acid bis(2-ethylhexyl)ester (BEH-TEBP)
Concentration
5 - 10
EC/CAS
200-857-2/75-28-5
Name of the chemical
iso-Butan, enthält 0,1% Butadien
Concentration
5 - 10
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
1 - 5
General Information
Version
1.1
Revision date
2023-09-05
Product name
PU Foam Fast Grip
1.2.1 Relevant identified uses
Professional use
supplier name
CRC Industries Europe B.V
Emergency telephone
+32(0)52/45.60.11, +32 70 245 245
Icons in SDS
Company Information
company name
CRC Industries Europe B.V
e-mail address of the competent person responsible for the Safety Data Sheet
hse@crcind.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H222, H229, H315, H317, H319, H332, H334, H335, H351, H373
Hazard statements
Code
Statements
H222
Extremely flammable aerosol
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Pressurised container: May burst if heated. Extremely flammable aerosol. Suspected of causing cancer. May cause damage to organs through prolonged or repeated exposure. Harmful if inhaled. May cause respiratory irritation. Causes skin irritation. May cause an allergic skin reaction. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled.
2.2 Label elements
Labelling
Hazard pictograms
GHS02 GHS07 GHS08
Signal word
Danger
Contains
diphenylmethane diisocyanate, isomers and homologues
Hazard statements
H222 - Extremely flammable aerosol. H229 - Pressurised container: May burst if heated. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H332 - Harmful if inhaled. H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled. H335 - May cause respiratory irritation. H351 - Suspected of causing cancer. H373 - May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P211 - Do not spray on an open flame or other ignition source. P251 - Do not pierce or burn, even after use. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call doctor, a POISON CENTER. P410+P412 - Protect from sunlight. Do not expose to temperatures exceeding 50 °C. P501 - Dispose of contents/container to a hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
Supplemental label elements
EUH204 - Contains isocyanates. May produce an allergic reaction.
Additional information
Persons already sensitised to diisocyanates may develop allergic reactions when using this product. Persons suffering from asthma, eczema or skin problems should avoid contact, including dermal contact, with this product. This product should not be used under conditions of poor ventilation unless a protective mask with an appropriate gas filter (i.e. type A1 according to standard EN 14387) is used. For professional users only. As from 24 August 2023 adequate training is required before industrial or professional use.
vPvB Substances
0.1% assessed in accordance with REACH Annex XIII Component Bis(2-ethylhexyl) tetrabromophthalate (26040-51-7) This substance meets the vPvB criteria of REACH regulation, annex XIII The mixture contains substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 Component Reaction products of phosphoryl trichloride and 2- methyloxirane(1244733-77-4) The substance is included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 2,2',6,6'-Tetrabromo-4,4'-isopropylidenediphenol, The substance is included in the list established in accordance with Article 59(1) of oligomeric reaction products with Propylene oxide and REACH for having endocrine disrupting properties, or is identified as having endocrine n-butyl glycidyl ether(1179964-22-7) disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605